<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR8">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zomerdijk</surname>
    <given-names>IM</given-names>
   </name>
   <name>
    <surname>Sayed-Tabatabaei</surname>
    <given-names>FA</given-names>
   </name>
   <name>
    <surname>Trifiro</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Blackburn</surname>
    <given-names>SC</given-names>
   </name>
   <name>
    <surname>Sturkenboom</surname>
    <given-names>MC</given-names>
   </name>
   <name>
    <surname>Straus</surname>
    <given-names>SM</given-names>
   </name>
  </person-group>
  <article-title>Risk minimization activities of centrally authorized products in the EU: a descriptive study</article-title>
  <source>Drug Saf</source>
  <year>2012</year>
  <volume>35</volume>
  <issue>4</issue>
  <fpage>299</fpage>
  <lpage>314</lpage>
  <pub-id pub-id-type="doi">10.2165/11594560-000000000-00000</pub-id>
  <pub-id pub-id-type="pmid">22339506</pub-id>
 </element-citation>
</ref>
